History of EECP

In 1953, cardiologists and scientists of Harvard University developed a principle of “phase shift diastolic augmentation”. This principle proved that the pressure on the heart during the palpitation could be reduced to prevent a heart attack. On this principle, External Enhanced Counterpulsation (EECP) developed. Because of the Harvard University research, heart surgery can be avoided by this EECP treatment. About a million heart patients across the globe have benefited from EECP treatment. It has been approved by US Food and Drugs Administration (USFDA), which regulates validity of medicines, machines and different ways of treatment world over Around 15,000 machines are carrying out EECP in the USA, UK, China and other European countries. Over 50,000 patients have been treated in India by the EECP treatment.

What is EECP/ECP Therapy?

EECP Therapy (“Enhanced External Counterpulsation Pulsation “) similar to “Natural Bypass” Therapy is an US FDA approved, Non- Surgical treatment for Heart patients suffering from angina (chest pain), Coronary Arteries Diseases (CAD), not eligible for surgeries (Angioplasty/Bypass) with blocked arteries, kidney failure, diabetes, hypertension and those who are suffering from Lifestyle Diseases. EECP Therapy improves the blood circulation to the heart, brain, Kidney & to the whole body and opens new blood vessels (Collaterals) which are given by God since birth, which is popularly known as “Natural Bypass”. EECP Therapy is an alternative to Bypass Surgery & Angioplasty (stents). EECP is a safe, non-pharmaceutical, non-invasive outpatient treatment for heart Patient . EECP Treatment / EECP Therapy is painless, carries no risk and has no side effects.